Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Astellas Venture Management

Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • UAE
  • Saudi Arabia
  • United Kingdom
  • USA
  • Spain
  • Germany
  • Nerlands
  • India
  • Pakistan
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Tech
  • Internet
  • Software
  • Services
About
Astellas Venture Management is the venture Capital arm of Astellas Pharma, dedicated to supporting early stage biotech companies with a focus on therapeutics. They provide Equity investments and strategic support to help companies accelerate their innovations.
Min check size
$100K
Max check size
$1M
Fund size
NPS

Investment Thesis

Astellas Venture Management focuses on early stage BioTech companies developing therapeutic programs and platform technologies. The aim is to support cutting edge science that aligns with Astellas Pharma's R&D strategy, providing strategic investment and leveraging pharma expertise to advance innovations.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

NeoPhore

TippingPoint Biosciences

Altay Therapeutics

Shinobi Therapeutics

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp